Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
Botson JK, Saag K, Peterson J, Parikh N, Ong S, La D, LoCicero K, Obermeyer K, Xin Y, Chamberlain J, LaMoreaux B, Verma S, Sainati S, Grewal S, Majjhoo A, Tesser JRP, Weinblatt ME. Botson JK, et al. Among authors: tesser jrp. Arthritis Rheumatol. 2023 Feb;75(2):293-304. doi: 10.1002/art.42335. Epub 2022 Dec 16. Arthritis Rheumatol. 2023. PMID: 36099211 Free PMC article. Clinical Trial.
The liver in rheumatic diseases.
Weinblatt ME, Tesser JR, Gilliam JH 3rd. Weinblatt ME, et al. Semin Arthritis Rheum. 1982 May;11(4):399-405. doi: 10.1016/0049-0172(82)90027-0. Semin Arthritis Rheum. 1982. PMID: 7048531 Review. No abstract available.
Chronic liver disease and Still's disease.
Tesser JR, Pisko EJ, Hartz JW, Weinblatt ME. Tesser JR, et al. Arthritis Rheum. 1982 May;25(5):579-82. doi: 10.1002/art.1780250514. Arthritis Rheum. 1982. PMID: 7082403 No abstract available.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Genovese MC, Kaine JL, Lowenstein MB, Del Giudice J, Baldassare A, Schechtman J, Fudman E, Kohen M, Gujrathi S, Trapp RG, Sweiss NJ, Spaniolo G, Dummer W; ACTION Study Group. Genovese MC, et al. Arthritis Rheum. 2008 Sep;58(9):2652-61. doi: 10.1002/art.23732. Arthritis Rheum. 2008. PMID: 18759293 Free article. Clinical Trial.
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
Botson JK, Tesser JRP, Bennett R, Kenney HM, Peloso PM, Obermeyer K, Song Y, LaMoreaux B, Zhao L, Xin Y, Chamberlain J, Ramanathan S, Weinblatt ME, Peterson J. Botson JK, et al. Among authors: tesser jrp. Arthritis Res Ther. 2022 Aug 25;24(1):208. doi: 10.1186/s13075-022-02865-z. Arthritis Res Ther. 2022. PMID: 36008814 Free PMC article.
A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings.
Botson JK, Saag K, Peterson J, Obermeyer K, Xin Y, LaMoreaux B, Padnick-Silver L, Verma S, Grewal S, Majjhoo A, Tesser JRP, Weinblatt ME. Botson JK, et al. Among authors: tesser jrp. ACR Open Rheumatol. 2023 Aug;5(8):407-418. doi: 10.1002/acr2.11578. Epub 2023 Jun 29. ACR Open Rheumatol. 2023. PMID: 37385296 Free PMC article.
49 results